Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Protein kinase C epsilon–Receptor for activated C kinase 1 (PKCε–RACK1) complex is a functional signaling unit where the scaffolding protein RACK1 anchors the activated PKCε enzyme to specific subcellular locations (Mochly-Rosen et al., Science, 1991). PKCε is a calcium-independent serine/threonine kinase that plays a pivotal role in various signal transduction pathways, but its activity is strictly dependent on its translocation to distinct cellular compartments. RACK1 facilitates this by binding to the C2-like domain of PKCε, ensuring the kinase is positioned near its specific substrates (Johnson et al., J Biol Chem, 1996). This protein-protein interaction is a key regulator of cardiac preconditioning, where it protects the heart from ischemia-reperfusion injury by facilitating mitochondrial translocation (Inagaki et al., Circulation, 2003). It also modulates neurotransmitter receptor sensitivity in the brain, influencing behaviors related to alcohol consumption and pain (Lesscher et al., Biological Psychiatry, 2009). In oncology, the PKCε–RACK1 interaction is often hijacked to promote cell migration and metastasis, making it a significant target for anti-cancer therapies. Pharmacological modulation of this complex typically involves isoform-specific peptides, such as the inhibitor εV1-2 or the activator ψεRACK, which provide a more targeted approach than traditional ATP-competitive kinase inhibitors.
Modulation of the protein-protein interaction between PKCε and its anchoring protein RACK1 to control the kinase's subcellular localization, activation state, and substrate access.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase C epsilon–Receptor for activated C kinase 1 complex (PKCε–RACK1 complex).